Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease

Epstein Barr virus (EBV)(+) Hodgkin's disease (HD) expresses clearly identified tumor antigens derived from the virus and could, in principle, be a target for adoptive immunotherapy with viral antigen–specific T cells. However, like most tumor-associated antigens in immunocompetent hosts, these...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bollard, Catherine M., Aguilar, Laura, Straathof, Karin C., Gahn, Benedikt, Huls, M. Helen, Rousseau, Alexandra, Sixbey, John, Gresik, M. Victoria, Carrum, George, Hudson, Melissa, Dilloo, Dagmar, Gee, Adrian, Brenner, Malcolm K., Rooney, Cliona M., Heslop, Helen E.
Format: Artigo
Langue:Inglês
Publié: The Rockefeller University Press 2004
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2211993/
https://ncbi.nlm.nih.gov/pubmed/15611290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20040890
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires